Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma. (Q53551125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Fredrik Pontén

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Helga B Salvesen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Per-Henrik D Edqvist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jutta Huvila

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Björn Forsström

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lauri Talve

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Olli Carpén

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Seija Grénman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Henrik Johannesson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Oscar Ljungqvist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

7 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

529-537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25858696%20AND%20SRC:MED&resulttype=core&format=json

Markers for individualised therapy in endometrial carcinoma

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Adjuvant chemotherapy for endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

The human asparaginase-like protein 1 hASRGL1 is an Ntn hydrolase with beta-aspartyl peptidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Uncoupling Intramolecular Processing and Substrate Hydrolysis in the N-Terminal Nucleophile Hydrolase hASRGL1 by Circular Permutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

The Human Protein Atlas as a proteomic resource for biomarker discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Proteomics. Tissue-based map of the human proteome

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

inferred from DOI database lookup

7 January 2021

based on heuristic

Towards a knowledge-based Human Protein Atlas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Selective enrichment of monospecific polyclonal antibodies for antibody-based proteomics efforts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Generation of monospecific antibodies based on affinity capture of polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Tissue microarray technology for high-throughput molecular profiling of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Validation of tissue microarray technology in endometrioid cancer of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055

Structures of Apo and Product-Bound Human l -Asparaginase: Insights into the Mechanism of Autoproteolysis and Substrate Hydrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.03.055